Biotechnology Stock Doubled This: Fund Bets 1.2M Shares
A large fund snapped up 1.2 million Vir Biotechnology shares as the stock doubled this past year. Here’s how to read ...
Identify whether a Backdoor Roth is right for you, focusing on income, taxes, and long-term retirement goals.
23,905 articlesA large fund snapped up 1.2 million Vir Biotechnology shares as the stock doubled this past year. Here’s how to read ...
A focused look at a large institutional bet on Indivior, the logic behind the $143 million investment, and how such m...
Ford and GM are reshaping their business models by moving into energy-related assets like batteries, charging network...
As Meta Platforms weighs renting out idle AI compute, investors ask if the company overbuilt. This piece breaks down ...
Meta just made striking moves in AI infrastructure that could tilt demand in Nvidia's favor. This deep dive explains ...
The Nasdaq-100 has delivered eye-catching runs, but 2026 brought a pause. This guide breaks down what to watch, how t...
Investors eye Omada Health as it reports Q1 2026 results. This analysis breaks down the earnings narrative, key metri...
A notable fund sold millions of dollars’ worth of shares as this obesity drug stock jumped on Phase 3 momentum. Here’...
Marvell Technology surprised the market with a stronger revenue outlook. This in-depth guide examines what that means...
When Alphabet stock just crashed, investors hunted for real reasons beyond headlines. This guide breaks down the core...
SpaceX is fueling ambitious AI bets with a massive cash runway. This article weighs that plan against two established...
A major fund reduced its TransAlta stake in Q4, sparking questions about the stock’s trajectory. This article explain...